Cellectar Biosciences Inc（CLRB）價格預測

$2.460

-0.049 (-1.99%)收盤時

價格預測

1-Day Price Prediction

+0.78%

1-Week Prediction

+4.33%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

CLRB 相似圖表分析預測

Alphio's CLRB stock price prediction model matches the current Cellectar Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.48 (+0.78%). The 1-week path is $2.57 (+4.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Cellectar Biosciences Inc 股票嗎？

Cellectar Biosciences Inc (CLRB) is a good buy right now due to its current price of $2.53, which is significantly below analyst price targets of $10 and $11, indicating potential upside. The company has reported a strong 87.5% overall response rate in its clinical trials, showcasing the efficacy of its treatment, which could lead to accelerated FDA approval. However, the main risk is its net income loss of $6.9 million in Q2 2026, which reflects ongoing financial challenges.

CLRB 股價於 Tuesday 收在 $2.46，此前下跌 -1.99%

Cellectar Biosciences Inc (CLRB) last closed at $2.46, losing -1.99%. These facts feed the 1-day and 1-week CLRB price prediction above.

預測驅動因素

Cellectar Biosciences Inc（CLRB）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 CLRB 最接近的股票，依相似度排序。

APP

84.90%

+29.78%

BKR

83.51%

-6.99%

SLS

83.21%

+58.18%

ONDS

83.01%

-5.59%

NVST

82.90%

-12.61%

CLRB 季節性分析

Historically the probability of a positive September return for CLRB is 0.00%. January offers the highest probability of a positive month at 50.82%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…